Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT03384901
NCT03384901UnknownNot Applicable

The Results of Pars Plana Vitrectomy in Diabetic Macular Edema

Hillel Yaffe Medical Center1 site in 1 country70 target enrollmentStarted: January 2018Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
70
Locations
1
Primary Endpoint
Visual acuity
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This study will be a retrospective analysis of vitrectomy results in patients suffering from diabetic macular edema.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diabetic macular edema patients after vitrectomy

Exclusion Criteria

  • •All others

Outcomes

Primary Outcomes

Visual acuity

Time Frame: 6 months

Visual acuity will be measured using the Snellen Chart before and after vitrectomy

Secondary Outcomes

  • Macular thickness(6 months)

Investigators

Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Pars Plana Vitrectomy Combined With Phacoemulsification Cataract Surgery in Phakic Diabetes Retinopathy PatientsDiabetic RetinopathyDiabetic Cataract
NCT04729023Zhongshan Ophthalmic Center, Sun Yat-sen University129
Completed
Not Applicable
Evaluation of Vitrectomy for Diabetic Macular EdemaDiabetic Macular EdemaDiabetic Retinopathy
NCT00709319Jaeb Center for Health Research87
Completed
Phase 3
PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DMEMacular EdemaDiabetic Retinopathy
NCT03660345Rush Eye Associates11
Unknown
Phase 1
Pars Plana Vitrectomy for Diabetic Fibrovascular Proliferation With and Without Internal Limiting Membrane PeelingPatients With Proliferative Diabetic Retinopathy Who Have Active Fibrovascular Proliferation
NCT00556244National Taiwan University Hospital40
Completed
Not Applicable
Macular Appearance After Diabetic VitrectomyProliferative Diabetic RetinopathyVitrectomy
NCT00737022National Taiwan University Hospital108